Background: Excision repair cross-complementation group 5 (ERCC5) gene plays an
Haplotype and diplotype analyses of variation in ERCC5 transcription
ERCC5 transcript abundance associated with allelic variation at these SNPs could result in variation in NER function in NBEC and lung cancer risk. (8) . Variation at rs2296147 is predicted to alter binding of the TP53 transcription factor 24 (19). Both rs751402 and rs2296147 are associated with lung cancer risk in molecular 25 epidemiologic studies (29, 38) . 26
Introduction
In a previous study, based on genotype analysis we found that SNPs rs751402 27 and rs2296147 were associated with inter-individual variation in allelic imbalance in 28 ERCC5 expression in NBEC (6).This observation suggests that one or both of these 29
SNPs affects ERCC5 cis-regulation. However, based on genotyping analysis it was not 30 possible to sort out with confidence the independent roles of rs751402 and rs2296147. 31
Further, the patterns of allelic imbalance variation observed indicated that one or more 32 cis-regulatory SNPs in addition to rs751402 and rs2296147 also played a role. One 33 candidate is rs17655, a common polymorphic site in the ERCC5 3' UTR reported to be 34 associated with lung cancer risk (20) . Genetic variation in the 3' UTR of a gene can play 35 a role in cis-regulation by influencing microRNA (miRNA) binding activity (25, 28, 35) . 36
In an effort to better characterize putative cis-acting genetic variants that serve 37 as expression Quantitative Trait Loci (eQTL) responsible for inter-individual variation in 38 ERCC5 transcript regulation, we used recently developed methods to assess in more 39 8 specific PCR amplification followed by Sanger sequencing (The University of 93
Michigan DNA Sequencing Core, Ann Arbor, MI) as described previously (6). An 94 overview of polymorphic sites and primers relative to ERCC5 gene coordinates is 95 depicted in Figure 1 . The sequences and design of allele-specific primers were 96 described previously (6). 97
It was not possible to conduct analysis in 11 of the 80 samples. In three 98 samples, there was no amplification due to poor quality of gDNA and cDNA; four 99 subjects were heterozygous at rs751402 but homozygous at rs2296147 and the 100 spanned region between rs751402 and rs1047768 was too long to assess 101 synteny by direct sequencing; four samples were not amplified with primers 102 determining rs2296147-rs1047768 synteny, likely due to variation in the 103 transcription start site as previously reported (6) . 104 Measurement of ERCC5 allele-specific and total expression 105 ERCC5 allelic-imbalance was measured in cDNA and matched gDNA 106 samples from each subject using a modified version of previously described 107 methods (5). Allelic-imbalance in gDNA was measured as a control for possible 108 SNP rs10477678 in the ERCC5 5'UTR region, SNP rs17655 in the 3'UTR region and, 116 the ACTB loading control gene, and b) a known number of internal standard molecules 117 for each of these targets. Each primer was designed with a universal tail sequence 118 (similar to that used for arrayed primer extension: APEX-2) not present in the human 119 genome to allow for multi-template PCR addition of barcode and platform specific 120 sequencing adapters. The internal standards mixture was prepared as described 121
previously (5). 122
Three sequential PCR amplifications were conducted to prepare the library prior 123 to sequencing. In the first reaction each target sequence was amplified with 5µM APEX-124 tailed primers using an air thermal cycler (RapidCycler; Idaho Technology, Inc. Idaho 125 Falls, Idaho), PCR conditions were 95°C/3min (Taq DNA polymerase activation); 35 126 cycles of 94°C/5sec (denaturation), 58°C/10sec (annealing), 72°C/15 sec (extension). 127
Each product from the first PCR was purified using QIAquick PCR purification kit 128 (Qiagen, Valencia, CA) to remove residual primers and primer dimers then used as 129 template for barcoding PCR. Each barcoding reaction was cycled in the air cycler under 130 the following conditions: 95°C/3min (Taq DNA polymerase activation); 15 cycles of 131 purification kit (Qiagen, Valencia, CA) to remove residual primers. The 139 concentration of purified products was checked by Bioanalyzer 2100 and then 140 sent for sequencing. ASE was presented as allelic ratio which was calculated as 141 the ratio of sequencing counts for each allele and filtered as described below. 142
Data processing pipeline

143
The University of Michigan Illumina Sequencing services provided raw 144 sequencing data in FASTQ format. Practical Extraction and Reporting Language 145 (PERL) scripts were used to combine Read 1 (forward) and Read 2 (reverse) 146 sequence reads for each template sequenced. These "joined" reads were then 147 de-multiplexed based on dual-index barcoding on each template, and the locus 148 was identified based on the region representing the primer sequences. 149
Intervening amplicon sequence that was "captured" between the primer 150 sequences was aligned using custom alignment with Approximate String 151 matching algorithm as previously described (3, 5). These alignment calls then 152 provided relative abundance in the form of sequence "counts" for each allele at 153 each locus. The ratio of these allele specific sequence counts at each locus then 154 represents the allele-specific expression ratio. 
Results
179
Inter-individual variation in allelic imbalance at 5'-UTR site rs1047768 180 ERCC5 allele-specific transcript expression was measured as allelic ratio in 181 NBEC cDNA samples from individuals heterozygous at the rs1047768 marker 182 polymorphic site located in the ERCC5 5'-UTR. For analysis of allelic imbalance at 183 rs1047768, data from the 80 newly enrolled subjects were combined with data from 81previously enrolled subjects (6). Among the newly enrolled subjects, thirty-three 185 individuals were heterozygous at the marker SNP rs1047768, while among the 186 previously enrolled subjects twenty-two were heterozygous (6). Allelic ratios for 187 the cDNA sample and matched gDNA sample from the same heterozygous 188 individuals are summarized in Supplementary Table 2 and presented graphically 189 in Figure 2 . Among 55 subjects that were heterozygous for rs1047768 the 190 variation in allelic ratio measured at polymorphic site rs1047768 for the group of 191 cDNA samples was significantly higher than that observed in matched gDNA 192
Characterization of haplotype and diplotype structure in ERCC5 5'-
For the150 individuals that were analyzed for haplotype structures 196 comprised by polymorphic sites rs751402-rs2296147-rs1047768, a variety of 197 structures were observed (Table 1) There was a significant difference in the mean allelic transcript ratio at the marker 212 polymorphic site rs1047768 among the six diplotype structure groups (p=0.0030). The 213 mean allelic transcript ratio among subjects with GTT/GCC diplotype was 1.2-fold 214 higher than that of subjects with diplotype GTT/GTC (p=0.0280) and 1.4-fold higher than 215 that of subjects with diplotype GCT/GTC (p=0.010). There was no difference in mean 216 allelic ratio between diplotype GTT/GCC and ATT/GCC (Figure 3) . 217
The rs1047768 allele (T or C) syntenic with rs2296147 T allele displayed higher 218 transcript abundance than the allele syntenic with rs2296147 C allele, regardless of 219 allele present at putative cis-regulatory polymorphic site rs751402 ( Figure 3 ). Consistent 220 with this, significantly 1.44-fold, 1.42-fold, and 1.22-fold higher (p<0.05) rs1047768 T/C 221 mean allelic ratio was observed in the combined group of subjects with either GTT/GCC 222 or ATT/GCC compared to any groups of subjects with GCT/GCC, GCT/GTC, or 223
GTT/GTC (Figure 3). 224
Inter-individual variation in allelic imbalance measured at rs17655 in
In addition to the polymorphic site rs1047768 near ERCC5 transcript 5'UTR, 227 allelic ratio was also measured at a polymorphic site close to ERCC5 transcript 3'UTR, 228 rs17655 in the 80 newly enrolled subjects. In measurement of gDNA samples, allelic 229 ratio results from 8 of 80 individuals failed to pass the filter of expected CV (see 230 "Filtering for stochastic sampling error" section in Materials and Methods) so 231 these eight individuals were excluded from subsequent analyses. After applying 232 quality control, 28 of 80 subjects were characterized as heterozygotes, 42 233 subjects were homozygous for G-allele, and 2 subjects were homozygous for C-234 allele. Among the 28 heterozygous subjects, after filter for expected CV, 21 had 235 valid allelic ratios in cDNA samples and matched gDNA samples. Among these 236 21 subjects, the mean G/C ratio was 30% higher in cDNA relative to matched 237 gDNA (t-test, p<0.0001) ( Figure 2B ). In addition, the variation in rs17655 G/C 238 allelic ratio was 2.2 times higher in cDNA samples compared to matched gDNA 239 samples (F-test, p=0.0005) . 
Contribution of 5'UTR SNPs to ERCC5 cis-regulation 250
Analysis of diplotype structure at rs751402-rs2296147-rs1047768 251 demonstrated that higher abundance of transcript from rs1047768 marker site C 252 or T allele was associated with T-allele at putative cis-regulatory SNP rs2296147 253 and not associated with variation at rs751402 (Figure 3) . Notably, rs2296147 T-allele 254 participates in formation of an in silico predicted TP53 transcription factor-binding site 255 (19) and that site is predicted to be lost when C-allele is present. In previous studies 256 TP53 upregulates ERCC5 transcription (17). Therefore, it is reasonable to hypothesize 257 that TP53 upregulates ERCC5 transcription more effectively when T allele is present at 258 rs2296147. In contrast to strong evidence for the cis-regulatory role of rs2296147 in 259 ERCC5 regulation, haplotype and diplotype data do not support a similar role for 260 rs751402. Haplotype-based analyses presented here demonstrated that rs2296147 acts 261 as an eQTL, while rs751402 does not. This is new information that it was not possible to 262 obtain based only on genotype-based analyses (6). 263
Contribution of 3'UTR SNPs to ERCC5 cis-regulation 264
We observed an increased mean G/C allelic ratio at rs17655 in cDNA compared 265 to matched gDNA controls ( Figure 2B ), indicating that this SNP or a SNP in linkage 266 disequilibrium with it influences ERCC5 transcript levels in NBEC. It is likely that the 267 functional SNP responsible for this observation is rs873601 which is linked to rs17655 268 and is predicted to alter binding of multiple miRNAs (13, 18, 37) . Specifically, the C 269 allele at SNP rs17655 is linked to G allele at rs873601 (D' = 0.95), which is putatively 270 more responsive to multiple miRNAs that will increase the rate of degradation and lower 271 abundance of transcripts originating from rs17655 C allele, consistent with the data 272 presented here. Data presented here support the need for functional studies to confirm 273 that rs873601 binds miRNA and that binding is associated with allele-specific 274
degradation. 275
The mean G/C allelic ratio observed at the rs17655 site among the gDNA 276 samples studied was 0.91, which was lower than the theoretical ratio of 1.0 (t-277 test, p=0.0004). This may result from slight difference between the two rs17655 278 alleles in PCR amplification efficiency, which would affect both gDNA and cDNA 279 analysis. It is very unlikely that this difference resulted from copy number 280 variation because the gDNA allelic ratio was not greater than 1.5 in any subject. 281
Matched pair analysis confirmed the significantly increased mean G/C ratio in 282 cDNA compared to gDNA. 283
Interaction between 5'UTR and 3'UTR SNPs in ERCC5 cis-regulation
284
Although the results reported here increase clarity regarding cis-regulation 285 of ERCC5 transcription, additional questions remain, some brought into focus by 286 these studies. For example, the data reported here support the hypothesis that 287 rs2296147 and rs17655 or SNPs linked to them influence transcription of 288 ERCC5. A testable hypothesis to explain these results is that there is a) higher 289 TP53-mediated ERCC5 transcription rate from rs2296147 T allele and b) higher 290 miRNA mediated ERCC5 transcript degradation at rs873601 G allele. In addition, 291 we observed that mean T/C ratio at marker SNP rs1047768 and mean G/C ratio 292 at SNP rs17655 were significantly higher than 1.0. However, we also observed 293 significant variation around the mean allelic ratio at each marker SNP. This 294 raises a question because, if rs2296147 and rs873601 each acted as 295 independent cis-regulatory variants without any contribution from the other (for 296 example, in regulation of separate alternative transcripts) or from any other cis-297 acting SNP, we would expect very little inter-individual variation around thesemean ratios. One likely explanation is that the predominantly expressed ERCC5 299 transcripts incorporate both marker SNPs (rs1047768 and rs17655). Because the 300 putative cis-regulatory sites (rs2296147 and rs873601) are unlinked, another testable 301 hypothesis is that the variation in allelic ratio measured at each marker SNP is due to 302 variation in structure of haplotypes comprising these sites. Testing this hypothesis will 303 require long-range allele-specific PCR. 304
Additional possible mechanisms for ERCC5 cis-regulation 305
Although the variants assessed in this study likely are the major factors in cis-306 regulation of ERCC5, variants not included in this study may have a smaller effect in the 307 population. This might include SNPs that have a large biological effect but are rare in 308 the population, or common SNPs that have less biological effect. Identification of either 309 will require analysis of a larger cohort. As possible additional mechanisms, the cis-310 regulatory sites rs751402 and rs2296147 assessed in present study are linked to 311 intronic polymorphic sites in ERCC5 gene (34). These intronic variants might affect 312 different splicing regulatory elements, leading to aberrant allele-specific splicing of 313 ERCC5 pre-mRNA (10, 23, 27) . 314
Value of transcript abundance regulation as intermediate lung cancer
risk marker 316
Consistent with a complex genetic mechanism of lung cancer risk, the effect size 317 of each DNA variant associated with lung cancer risk is very small. Consequently, 318 thousands of subjects are needed to directly assess the association of individual genetic 319 variants and lung cancer risk (16). The data presented here support the conclusion that 320 inherited variation in gene regulation is a powerful intermediate phenotypic marker for 321 lung cancer risk, as presented schematically in Figure 4 . As we report here and 322 previously (6), it is possible to assess this type of intermediate risk factor with far 323 fewer patients than the thousands typically necessary for a GWAS study aiming 324 to determine association of each individual SNP with risk (1). Specifically, the 325 association of a single genetic variant with transcription regulation (e.g., 326 rs2296147 with ERCC5 regulation) or the association of inter-individual variation 327 in transcript abundance pattern with lung cancer risk may be assessed with 328 hundreds of subjects (2). For example, starting with 161 subjects we observed 329 significant association of rs2296147 genotype with ERCC5 ASE (Figure 3 ), and 330 with fewer than 100 subjects we observed significantly altered ERCC5 regulation 331 with lung cancer (22) (data not shown). In contrast, there was not a clear 332 association of rs2296147 T allele dosage with lung cancer risk among the 333 subjects enrolled for this study (data not shown). 334
These findings provide evidence that supports, as a strategy to identify 335 variants associated with lung cancer risk, analysis of NBEC regulation of key 336 antioxidant, DNA repair, and cell cycle control genes, followed by identification of 337 cis-regulatory variants associated with sub-optimal regulation. 338
339
Conclusion
340
Based on the findings in the current study, we conclude that rs2296147 is 341 an eQTL for ERCC5, and that the T allele at rs2296147 is associated with higher 342 ERCC5 transcript abundance, possibly through increased responsiveness to 343 TP53 transcription factor. Genotype at rs17655 also is associated with variationin ERCC5 transcript abundance, likely due to effect on miRNA binding affinity at the 345 linked SNP rs873601. These effects on ERCC5 transcription likely result in variation in 346 nucleotide excision DNA repair function. These findings provide a plausible explanation 347 for the association of genotype at rs2296147 and rs17655 with lung cancer risk. Tables   Table 1. Summary of haplotype structures in ERCC5 5'-UTR region from 70 newly recruited subjects and 80 previously enrolled subjects (N=150). rs751402 rs2296147 rs1047768 Haplotype Count Frequency The syntenic relationship of alleles at rs751402, rs2296147 and rs1047768 in individuals heterozygous for rs1047768 was assessed by allele-specific PCR amplification followed by direct sequencing. C allele Reverse Primer, a C-allelespecific-primer used in combination with Forward Primer for specific amplification from C allele at rs2296147 to determine synteny between alleles at rs2296147 and rs751402.
T-allele Forward Primer and C-allele Forward Primer were used in combination with
Reverse Primer in exon 2 for specific amplification from T allele or C allele, respectively, at rs2296147 to determine the synteny between alleles at rs2296147 and rs1047768. cDNA instead of gDNA was used for this amplification to avoid a large intron 1. The depicted cluster region of TSS represents highly variable ERCC5 transcription initiation sites as discussed previously (6). (B) The allele-specific expression of ERCC5 was measured at two polymorphic sites, rs1047768 and rs17655. Generally, native templates in cDNA sample were amplified with a known number of internal standards which contain identical priming sites and 6 nucleotides altered relative to native template. Barcodes that allowed for multiplexing and adapters specific for Illumina HiSeq platform were added by PCR. The products were quantified and purified then sent for sequencing on Illumina HiSeq. Asterisk indicates nucleotide alteration in internal standard (IS) relative to native template (NT). ANOVA was used to assess the difference in T/C allelic ratios among groups. All effects were statistically significant at the 0.05 significance level. Allelic ratios in relationship with six presented diplotypes at rs751402, rs2296147 and rs1047768 in ERCC5 5'UTR and exon 2. ANOVA revealed a significant difference in the mean allelic transcript ratio among the six diplotype groups (p=0.0030). The mean allelic transcript ratio among subjects with GTT/GCC diplotype (group 5) was 1.2-fold higher (p=0.0280) than that of subjects with GTT/GTC diplotype (group 6) and 1.4-fold higher (p=0.010) than that of subjects with GCT/GTC diplotype (group 4). There was no significant difference in mean allelic ratio between diplotype GTT/GCC and ATT/GCC (group 1) so they were combined and presented as NTT/GCC (group 7, N represents either G or A). The rs1047768 allele (T or C) syntenic with rs2296147 T allele displayed higher transcript abundance than the allele syntenic with rs2296147 C allele, regardless of allele present at rs751402. Consistent with this, significantly 1.44-fold, 1.42-fold, and 1.22-fold higher (p<0.05) mean allelic ratio was observed in group 7 compared to any groups of subjects with group 3, 4, 6, respectively. SNPs that affect transcript abundance regulation are indicated numerically and as diamonds (trans-regulatory SNPs) or circles (cis-regulatory SNPs). As indicated, each individual is at increased risk due to sub-optimal regulation of a different combination of genes. Further, when the same gene is sub-optimally regulated in multiple individuals (e.g., Gene C in Individuals 1 and 3), a different set of SNPs may be responsible in each individual. 
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